Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TherapeuticsMD Inc TXMD

Healthcare
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD... see more

Recent & Breaking News (NDAQ:TXMD)

TherapeuticsMD Announces Appointment of Mark Glickman as Chief Business Officer

Business Wire October 15, 2021

Therapeutics MD Is Urging Women to 'Take Pause' During Menopause Awareness Month

Business Wire September 2, 2021

TherapeuticsMD Announces Issuance of a J-Code for ANNOVERA® to Be Utilized in the Public Health Sector

Business Wire August 23, 2021

TherapeuticsMD Announces Appointment of Hugh O'Dowd as President

Business Wire August 9, 2021

TherapeuticsMD Announces Second Quarter 2021 Financial Results

Business Wire August 4, 2021

TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021

Business Wire July 26, 2021

TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA

Business Wire May 25, 2021

TherapeuticsMD Announces First Quarter 2021 Financial Results

Business Wire May 6, 2021

TherapeuticsMD to Report First Quarter 2021 Results on May 6, 2021

Business Wire April 29, 2021

TherapeuticsMD and Theramex Announce the Approval of BIJUVE® Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA® in Belgium

Business Wire April 8, 2021

TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results

Business Wire March 2, 2021

TherapeuticsMD Announces Participation in Upcoming Investor Conferences

Business Wire March 1, 2021

TherapeuticsMD to Report Fourth Quarter 2020 Results on March 2, 2021

Business Wire February 23, 2021

TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock

Business Wire February 16, 2021

TherapeuticsMD Announces Pricing of $110 Million Public Offering of Common Stock

Business Wire February 11, 2021

TherapeuticsMD Announces Underwritten Public Offering of its Common Stock

Business Wire February 10, 2021

TherapeuticsMD Announces Participation in Upcoming Investor Conferences

Business Wire December 29, 2020

Comedian Whitney Cummings Partners with TherapeuticsMD to Launch "Just Say Vagina"

Business Wire December 15, 2020

TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock

Business Wire November 13, 2020

TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference

Business Wire November 13, 2020